BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1416879)

  • 21. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
    Arisawa M; Sekine Y; Shimizu S; Takano H; Angehrn P; Then RL
    Antimicrob Agents Chemother; 1991 Apr; 35(4):653-9. PubMed ID: 1906261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents.
    Cheng AF; Ling TK; Lam AW; Fung KS; Wise R
    J Antimicrob Chemother; 1993 May; 31(5):699-709. PubMed ID: 8335498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems.
    Jones RN; Erwin ME; Barrett MS; Johnson DM; Briggs BM
    Diagn Microbiol Infect Dis; 1991; 14(4):301-9. PubMed ID: 1889181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.
    Chin NX; Gu JW; Fang W; Neu HC
    Diagn Microbiol Infect Dis; 1992; 15(4):331-7. PubMed ID: 1611848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
    Asahi Y; Miyazaki S; Yamaguchi K
    Antimicrob Agents Chemother; 1995 May; 39(5):1030-7. PubMed ID: 7625784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
    Mitsukude M; Inoue M; Mitsuhashi S
    Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals.
    Murphy SP; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1994 Sep; 20(1):49-55. PubMed ID: 7867299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro and in-vivo antibacterial activities of E1040, a new cephalosporin with potent antipseudomonal activity.
    Hiruma R; Otsuki M; Tashima M; Obana Y; Nishino T
    J Antimicrob Chemother; 1990 Dec; 26(6):769-81. PubMed ID: 2127928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
    Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    Pillar CM; Aranza MK; Shah D; Sahm DF
    J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of cefpirome against microorganisms isolated in haematology, oncology and intensive care units in Switzerland.
    Liassine N; Bille J; Breer C; Frei R; Wüst J; Auckenthaler R
    Scand J Infect Dis; 1997; 29(6):615-21. PubMed ID: 9571744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.
    Neu HC; Chin NX; Labthavikul P
    Infection; 1985; 13(3):146-55. PubMed ID: 3928497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro and in-vivo antibacterial activity of LB10517, a novel catechol-substituted cephalosporin with a broad antibacterial spectrum.
    Song HK; Oh JI; Kim MY; Kim YZ; Kim IC; Kwak JH
    J Antimicrob Chemother; 1996 Apr; 37(4):711-26. PubMed ID: 8722537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antimicrobial activity of cefpirome, a new cephalosporin.
    Wise R; Andrews JM; Cross C; Piddock LJ
    J Antimicrob Chemother; 1985 Apr; 15(4):449-56. PubMed ID: 3874198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin.
    Nakagawa S; Sanada M; Matsuda K; Hashizume T; Asahi Y; Ushijima R; Ohtake N; Tanaka N
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1423-7. PubMed ID: 2510590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.